Coastlands Capital LP
10% Owner

Coastlands Capital LP insider trades: Adial Pharmaceuticals (ADIL) stock purchases

10% Owner, Adial Pharmaceuticals Last trade Jul 16, 2026 4 Form 4 filings
$0
Sold, last 12 months
0 sales
$127K
Bought, last 12 months
3 buys
3
Open-market trades
since 2026
3
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Coastlands Capital LP reports to the SEC

Open-market buys and sales

3 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 16, 2026ADIL↑ Buy$9K
Jun 29, 2026ADIL↑ Buy$65K
Jun 17, 2026KTTA↑ Buy$53K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Coastlands Capital LP's insider trades

Coastlands Capital LP is a 10% owner of Adial Pharmaceuticals (ADIL). Since Jun 17, 2026, it has reported 3 open-market purchases worth $127K and no sales on SEC Form 4. In the last 12 months: 3 buys ($127K).

Its filings also include other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ADIL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.